Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 10/10/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–10/09/2026 Record Record Date Vuga Group Change Status Recency Days Research Attention Score Autologous Platelet-Rich Plasma Intra-ovarian Infusion in Poor Responders 05/06/2019 INTERVENTIONAL not-comparable 2,714.75 0 Women's Advanced Risk-assessment in Manitoba 05/06/2019 OBSERVATIONAL not-comparable 2,714.75 0 Usability Study of the Sensors and eMOM GDM Application 05/08/2019 OBSERVATIONAL not-comparable 2,712.75 0 Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer 05/08/2019 INTERVENTIONAL not-comparable 2,712.75 0 Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery 05/09/2019 INTERVENTIONAL not-comparable 2,711.75 0 Prospective Laboratory Study Biologic Specimens and Tumor Tissue of Patients With Cancer 05/09/2019 OBSERVATIONAL not-comparable 2,711.75 0 Phase III Study of MR-Guided Focused Ultrasound Surgery for the Treatment of Uterine Fibroids Compared to Myomectomy 05/14/2019 INTERVENTIONAL not-comparable 2,706.75 0 Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer 05/14/2019 INTERVENTIONAL not-comparable 2,706.75 0 The CoPenHagen PREeClampsia and cardIOvascUlar diSease Study 05/14/2019 OBSERVATIONAL not-comparable 2,706.75 0 Autologous Platelet Rich Plasma (PRP) Intra Ovarian Infusion in Perimenopausal Women 05/15/2019 INTERVENTIONAL not-comparable 2,705.75 0 Platino-resistance in Ovarian Cancer 05/17/2019 INTERVENTIONAL not-comparable 2,703.75 0 High-Resolution Lower Dose Dedicated Breast Computed Tomography (CT) 05/17/2019 INTERVENTIONAL not-comparable 2,703.75 0 Clinical Trial of Minimally Invasive Surgery Versus Abdominal Surgery in Patients With Early Stage Cervical Cancer 05/20/2019 INTERVENTIONAL not-comparable 2,700.75 0 TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer 05/20/2019 INTERVENTIONAL not-comparable 2,700.75 0 Physiotherapy Treatment for Gynecological Cancer Survivors With Urinary Incontinence 05/21/2019 INTERVENTIONAL not-comparable 2,699.75 0 Clinico-biological Data Collection Study of Metastatic Breast Cancer 05/21/2019 INTERVENTIONAL not-comparable 2,699.75 0 AKT Inhibitor, Ipatasertib, With Endocrine and CDK 4/6 Inhibitor for Patients With Metastatic Breast Cancer (TAKTIC) 05/22/2019 INTERVENTIONAL not-comparable 2,698.75 0 Cancer Activity and Lifestyle Measurement Study 05/23/2019 OBSERVATIONAL not-comparable 2,697.75 0 Quality of Life, Aesthetic Result and Health Economy in Breast Reconstruction 05/24/2019 INTERVENTIONAL not-comparable 2,696.75 0 PET/MR Versus CECT Scans in Imaging Patients With Ovarian Cancer or Highly Suspected Ovarian Cancer 05/29/2019 INTERVENTIONAL not-comparable 2,691.75 0 A Pilot Study of Quantitative Tumor Oxygen Measurements in Cervical Cancer 05/31/2019 OBSERVATIONAL not-comparable 2,689.75 0 Tocolysis in the Management of Preterm Premature Rupture of Membranes Before 34 Weeks of Gestation 06/05/2019 INTERVENTIONAL not-comparable 2,684.75 0 Three Fraction Radiation to Induce Immuno-Oncologic Response 06/07/2019 INTERVENTIONAL not-comparable 2,682.75 0 A Study of Evaluating The Effects Of Pyrotinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer 06/10/2019 INTERVENTIONAL not-comparable 2,679.75 0 Fetal Endotracheal Occlusion (FETO) in the Resolution of Pulmonary Hypertension in Fetuses With Severe CDH 06/10/2019 INTERVENTIONAL not-comparable 2,679.75 0 ANgiogenic Function at NOrmal TErm on Placenta 06/11/2019 OBSERVATIONAL not-comparable 2,678.75 0 A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer 06/11/2019 INTERVENTIONAL not-comparable 2,678.75 0 Combination Neoadjuvant Chemotherapy With or Without Apatinib for HER2 Negative Breast Cancer 06/11/2019 INTERVENTIONAL not-comparable 2,678.75 0 Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial) 06/12/2019 INTERVENTIONAL not-comparable 2,677.75 0 A Study of Limited Heart Monitoring During Non-anthracycline Trastuzumab-based Therapy in Breast Cancer Patients 06/12/2019 OBSERVATIONAL not-comparable 2,677.75 0 Sexual Health Empowerment for Women's Health 06/13/2019 INTERVENTIONAL not-comparable 2,676.75 0 Reproductive Axis Maturation in the Early Post-Menarchal Years 06/14/2019 OBSERVATIONAL not-comparable 2,675.75 0 Exercise Treatment With Standard Therapy for Metastatic Breast Cancer 06/17/2019 INTERVENTIONAL not-comparable 2,672.75 0 Study of Pembrolizumab in Metastatic HER2-negative Breast Cancer Patients With APOBEC3B Mutation 06/18/2019 INTERVENTIONAL not-comparable 2,671.75 0 Primary Ovarian Insufficient Patients 06/18/2019 OBSERVATIONAL not-comparable 2,671.75 0 Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial 06/19/2019 INTERVENTIONAL not-comparable 2,670.75 0 PCOS (Polycystic Ovarian Syndrome) Patients 06/19/2019 OBSERVATIONAL not-comparable 2,670.75 0 Safety Study for Prospective Assessment of Pregnancy Outcomes in Patients Treated With Tildrakizumab 06/20/2019 OBSERVATIONAL not-comparable 2,669.75 0 Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey 06/21/2019 INTERVENTIONAL not-comparable 2,668.75 0 Palliative Radiation for Advanced Cervical Cancer 06/25/2019 INTERVENTIONAL not-comparable 2,664.75 0 Efficacy, Immunogenicity and Safety of V503 in Chinese Women Aged 20-45 Years (V503-023) 06/26/2019 INTERVENTIONAL not-comparable 2,663.75 0 Docetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer 06/28/2019 INTERVENTIONAL not-comparable 2,661.75 0 Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery 07/01/2019 INTERVENTIONAL not-comparable 2,658.75 0 Hepcidin and Glucose Metabolism 07/05/2019 INTERVENTIONAL not-comparable 2,654.75 0 Bariatric Surgery for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium 07/05/2019 INTERVENTIONAL not-comparable 2,654.75 0 Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast 07/05/2019 INTERVENTIONAL not-comparable 2,654.75 0 Development of Variable Volume Automated Mandatory Boluses for Patient-controlled Epidural Analgesia During Labour 07/08/2019 INTERVENTIONAL not-comparable 2,651.75 0 Vital Signs-Integrated Patient-Assisted Intravenous Opioid Analgesia for Post Surgical Pain 07/08/2019 INTERVENTIONAL not-comparable 2,651.75 0 Arm and Finger Measurement for Blood Pressure Surveillance 07/09/2019 OBSERVATIONAL not-comparable 2,650.75 0 Geospatial Analysis of Neighborhood Environmental Stress in Relation to Biological Markers of Cardiovascular Health and Health Behaviors in Women 07/10/2019 OBSERVATIONAL not-comparable 2,649.75 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 10/10/2026 · upstream last modified 10/10/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Research Attention Score using the documented compute method. · methodology